Allogeneic HB-adMSCs vs Placebo for the Treatment of Acute Kidney Injury

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2024
This study aims to investigate, through the collection of valid scientific evidence necessary to determine safety and effectiveness, the potential use of Allogeneic Hope Biosciences Adipose-derived Mesenchymal Stem Cells (HB-adMSCs) to prevent progression of trauma-induced Acute Kidney Injury (AKI).
Epistemonikos ID: c9af32e9413df244b0b5f30e9a996ecda57010ed
First added on: Apr 17, 2025